国常会：更大力度推动房地产市场止跌回稳

Group 1: Free Trade Zone Initiatives - The State Council is promoting the replication of pilot measures from the China (Shanghai) Free Trade Zone to enhance institutional innovation and high-level opening-up, aiming for deeper reforms and high-quality development [3][4] - Since 2013, China has established 22 Free Trade Zones across various regions, creating a comprehensive reform and opening-up innovation framework [3] - In 2024, the Shanghai Free Trade Zone is projected to achieve an import and export volume of 2.25 trillion yuan, a year-on-year increase of 2.1%, accounting for 52.7% of Shanghai's total import and export value [3] Group 2: Real Estate Development - The meeting emphasized the importance of constructing a new model for real estate development to ensure a stable and healthy market, focusing on long-term strategies and systematic policy support [6] - Various regions, including Hunan and Jiangsu, have introduced specific plans for "good housing" construction, aiming to meet diverse housing needs and improve residential quality [7] - Recent reports indicate that the total transaction volume of new and second-hand homes in China has stabilized, suggesting a potential bottoming out of the real estate market [7] Group 3: Credit Repair Mechanism - The meeting highlighted the need to establish a unified and efficient credit repair mechanism to assist entities in rebuilding their credit [9] - Efforts are being made to enhance data sharing and collaboration among departments to streamline the credit repair process [9] - In 2023, initiatives in various regions have successfully helped thousands of enterprises restore their credit through improved services and innovative processes [9] Group 4: Drug and Medical Supplies Procurement - The meeting called for the evaluation and standardization of drug and medical supplies procurement policies to ensure effective collaboration in the healthcare sector [12] - By 2025, the National Medical Insurance Administration plans to continue promoting centralized procurement of drugs and medical supplies, with significant participation from numerous enterprises [12] - As of May 23, 2023, 136 drug varieties have met the conditions for procurement, indicating a robust market for pharmaceutical products [12]